SIRT2 and non-small cell lung carcinoma: It has been reported that SIRT2 expression is downregulated in ovarian cancer (Sun et al., 2019), prostate cancer (Damodaran et al., 2017), non-small cell lung cancer (Xu et al., 2015) and colorectal cancer (F. Du et al., 2020).